HUGO ID Detailed Result 3951


HUGO ID 3951
Symbol FXN
Name frataxin
#Occurrence 92
#Paper 6

 


PMID Match String Actual String Score Flanking text Edited by Edit
11679167FRDAFRDA2.0in diseases related to oxidative stress such as ALS or FRDA (see see Sections 4.3 and 4.4 
11679167FRDAFRDA2.0Friedreich's ataxia (FRDA) FRDA 
15896810FRDAFRDA4.3neurodegenerative diseases including Parkinson's disease Alzheimer's disease Friedreich's ataxia (FRDA), FRDA multiple sclerosis and amyotrophic lateral sclerosis may involve the generation 
15896810FRDAFRDA4.3The precise sequence of events in FRDA pathogenesis is uncertain 
15896810FRDAFRDA4.3addition that decreased expression of frataxin protein is associated with FRDA 
15896810FRDAFRDA4.3Many approaches have been undertaken to understand FRDA but the heterogeneity of the etiologic factors makes it difficult 
15896810FRDAFRDA4.3and their interaction in a vicious cycle are central to FRDA pathogenesis 
15896810FRDAFRDA4.3Brains of FRDA patients undergo many changes such as disruption of protein synthesis 
15896810FRDAFRDA4.3ALS multiple sclerosis (MS), MS Huntington's disease (HD) HD and FRDA are all associated with the presence of abnormal proteins 
15896810FRDAFRDA4.3neurodegenerative diseases including Alzheimer's and Parkinson's diseases ALS MS and FRDA 
15896810FRDAFRDA4.3may play an essential role in neurodegenerative diseases such as FRDA 9 
15896810FRDAFRDA4.3The precise sequence of events in FRDA pathogenesis is uncertain 
15896810FRDAFRDA4.3addition that decreased expression of frataxin protein is associated with FRDA 11 
15896810FRDAFRDA4.3the oxidative stress hypothesis which may underlie the pathogenesis of FRDA 
15896810FRDAFRDA4.3FRDA is an autosomal recessive degenerative disorder characterized by progressive gait 
15896810FRDAFRDA4.3Neuropathology in FRDA is characterized by early degeneration of large sensory neurons in 
15896810FRDAFRDA4.3Hypertrophic cardiomyopathy is present in large proportion FRDA patients 12 and 13 
15896810FRDAFRDA4.3The causative mutation of FRDA is an abnormally expanded GAA triplet repeat in the first 
15896810FRDAFRDA4.3expanded GAA triplet repeat in the first intron of the FRDA gene on chromosome 9q13 14 
15896810FRDAFRDA4.3Ninety-eight percent of FRDA patients are homozygous for the GAA expansion the remainder carrying 
15896810FRDAFRDA4.3GAA expansion the remainder carrying a repeat expansion in one FRDA allele and a point mutation in the other 12 and 
15896810FRDAFRDA4.3The size of the GAA expansion in FRDA patients ranges from about 100 repeats to 1700 12 and 
15896810FRDAFRDA4.3The expression of a number of symptoms/signs symptoms signs in FRDA is dependent upon the length of the GAA repeat expansion 
15896810FRDAFRDA4.3Mutations in the FRDA gene either GAA expansions or point mutations result in reduced 
15896810FRDAFRDA4.3In normal subjects the highest level of expression of the FRDA gene has been found in the heart and spinal cord 
15896810FRDAFRDA4.3The amount of residual frataxin in lymphoblastoid cell lines from FRDA patients correlates with the GAA expansion size in the smaller 
15896810FRDAFRDA4.3been demonstrated in post-mortem cardiac muscle samples from patients with FRDA associated with reduced levels of mitochondrial DNA and with increased 
15896810FRDAFRDA4.3protein manganese superoxide dismutase (MnSOD) MnSOD fails to occur in FRDA fibroblasts exposed to iron 25 
15896810FRDAFRDA4.3Cardiac and skeletal muscle bioenergetics was investigated directly in FRDA patients using in vivo 31 P-MRS 41 
15896810FRDAFRDA4.3Cardiac bioenergetics was assessed in vivo in FRDA patients with and without left ventricular hypertrophy 43 
15896810FRDAFRDA4.3Cardiac PCr to ATP ratios in the FRDA group as a whole were reduced by about 40% 
15896810FRDAFRDA4.3were significantly reduced compared to controls in both groups of FRDA patients with normal and hypertrophic heart 43 
15896810FRDAFRDA4.3In FRDA the hypertrophic process may be compensatory and caused or contributed 
15896810FRDAFRDA4.3have shown a reduced rate of mitochondrial ATP synthesis in FRDA patients 46 and 47 
15896810FRDAFRDA4.3Mitochondrial V max for ATP production in FRDA patients was also significantly lower than in a group of 
15896810FRDAFRDA4.3se did not account for the reduced mitochondrial function in FRDA patients 
15896810FRDAFRDA4.3utilization of oxygen in response to exercise showed in several FRDA patients features related to inadequate oxygen utilization by muscle 48 
15896810FRDAFRDA4.3glutathione bound to haemoglobin in erythrocytes have been demonstrated in FRDA patients 128 also associated with a significant elevation in the 
15896810FRDAFRDA4.3Therapy advances in FRDA 
15896810FRDAFRDA4.3The precise sequence of events in FRDA pathogenesis is uncertain 
15896810FRDAFRDA4.3FRDA offers a unique opportunity to intervene with _amp_#x201c neuroprotective_amp_#x201d therapy 
15896810FRDAFRDA4.3in the presence of advanced disease and established pathogenetic mechanisms FRDA patients can be diagnosed by genetic analysis either presymptomatically or 
15896810FRDAFRDA4.3free radical production and deficit of oxidative phosphorylation shown in FRDA suggests that the mitochondrial respiration deficit may be amenable to 
15896810FRDAFRDA4.3Three FRDA patients were treated for 4 to 9 months with idebenone 
15896810FRDAFRDA4.3equal or more than 20% in 17 out of 38 FRDA patients 173 and by two more recent idebenone trials 174 
15896810FRDAFRDA4.3daily also resulted in decreased markers of oxidative stress in FRDA patients 176 
15896810FRDAFRDA4.3hypertrophy (LVH) LVH and ataxia has been evaluated in ten FRDA patients 177 After 6 months of therapy cardiac PCr to 
15896810FRDAFRDA4.3FRDA patients assessed neurologically using the semi-quantitative International Cooperative Ataxia Rating 
15896810FRDAFRDA4.3oxidative stress has been recently investigated in cultured fibroblasts from FRDA patients in which glutathione synthesis have been blocked 
15896810FRDAFRDA4.3Targeted antioxidants may have therapeutic potential in FRDA and in other disorders involving mitochondrial oxidative damage 
15896810FRDAFRDA4.3Given the physiopathological mechanisms responsible for FRDA selenium administration could represent another therapy strategy 
15896810FRDAFRDA4.3address the toxicity of GPX mimetics in humans before human FRDA trials can be considered 
15896810FRDAFRDA4.3screening of compounds that have potential in the treatment of FRDA 183 
15896810FRDAFRDA4.3Since the discovery of the genetic basis of FRDA only few years ago the progress made in our understanding 
15896810FRDAFRDA4.3progress made in our understanding of the pathogenic mechanisms underlying FRDA has been remarkable 
15896810FRDAFRDA4.3the precise function of frataxin still remains to be defined FRDA has clearly been identified as a nuclear encoded mitochondrial disorder 
15896810FRDAFRDA4.3randomised trials which will confirm whether an early diagnosis of FRDA can be exploited to initiate antioxidant treatment and prevent the 
17191135FRDAFRDA1.5amyotrophic lateral scelrosis (ALS) ALS and Friedreich_amp_#8217 s ataxia (FRDA) FRDA belong to the so-called _amp_#8220 protein conformational diseases_amp_#8221 4 
10742195frataxinfrataxin1.0friedrich_amp_#x2019;s ataxia fa is a disease characterized by neurodegeneration and cardiomyopathy and is caused by a mutation of frataxin a mitochondrial protein involved in iron homeostasis and respiratory function.  
10742195frataxinfrataxin1.0frataxin has recently been shown to export non heme bound iron from the mitochondria hence the mutation appears to cause a loss of function that raises iron levels in the mitochondria [ 50 ].  
11679167frataxinfrataxin1.0this disorder results from a deficiency in frataxin a nuclear encoded mitochondrial protein with no homology to proteins of known function.  
11679167frataxinfrataxin1.0studies on the yeast frataxin homologue yfh1p suggest that this protein is an iron binding protein that plays a key role in regulation of iron homeostasis and resistance to oxidative stress.  
11679167frataxinfrataxin1.0indeed yfh1p exhists as a monomer in the absence of iron but self aggregates in the presence of iron forming multimers able to sequester more than 16 iron atoms per frataxin molecule adamec et al. 2000 .  
11679167frataxinfrataxin1.0both frataxin and yfh1p are processed in the mitochondria to a mature form that is essential for the control of mitochondrial iron homeostasis knight et al. 1998 ; branda et al. 1999 ; cavadini et al. 2000 .  
11679167frataxinfrataxin1.0as the excess of iron is known to promote the formation of the highly reactive hydroxyl radicals the absence of an oxidative stress response may account for cellular dysfunction of frataxin deficient mutants.  
15031734frataxinfrataxin1.0we have proposed that the proteins implicated in several age dependent neurodegenerative disorders a beta in ad alpha synuclein in pd sod1 in als frataxin in friedreich's ataxia box 1 and alpha b crystallin in cataracts might abnormally present cu 2+ or fe 3+ ligands for inappropriate reaction with o 2 fig 1 .  
15031734frataxinfrataxin1.0beta actin catalase creatine kinase frataxin glucose transporter type 3 glutathione peroxidase glutathione reductase mitogen activated protein kinase 1 sod alpha synuclein xanthine dehydrogenase  
15480846friedreich ataxiafriedreich ataxia1.0iron has been shown to accumulates at site where neurons degenerate in neurodegenerative diseases of parkinson s disease alzheimer s disease huntington disease amyotrophic lateral sclerosis and friedreich ataxia.  
15896810frataxinfrataxin1.0recent evidence suggests that frataxin might detoxify ros via activation of glutathione peroxidase and elevation of thiols and in addition that decreased expression of frataxin protein is associated with frda.  
15896810frataxinfrataxin1.0there is now evidence to suggest that frataxin might detoxify ros via activation of glutathione peroxidase and elevation of thiols [10] and in addition that decreased expression of frataxin protein is associated with frda [11] .  
15896810friedreich ataxiafriedreich ataxia1.0clinical and genetic features of friedreich ataxia  
15896810friedreich ataxiafriedreich ataxia1.0friedreich ataxia is the commonest form of inherited ataxia with a frequency of 1 in 50 000 live births.  
15896810frataxinfrataxin1.0mutations in the frda gene either gaa expansions or point mutations result in reduced expression of a protein called frataxin [16] which has been shown to be localized to mitochondria [16] [17] and [18] .  
15896810frataxinfrataxin1.0the amount of residual frataxin in lymphoblastoid cell lines from frda patients correlates with the gaa expansion size in the smaller allele [16] and likely represents the molecular basis of the relationship between gaa expansion s 
15896810friedreich ataxiafriedreich ataxia1.0there is significant evidence that the pathogenesis of several neurodegenerative diseases including parkinson's disease alzheimer's disease friedreich ataxia multiple sclerosis and amyotrophic lateral sclerosis may involve the generation of reactive oxygen species ros reactive nitrogen species rns and mitochondrial dysfunction.  
15896810frataxinfrataxin1.0studies using the budding yeast saccharomyces cerevisiae have provided the first clues to understand the consequences of frataxin loss [17] [18] [19] [20] and [21] .  
15896810frataxinfrataxin1.0it has been shown that deletion of the yeast frataxin homolog yfh1 results in a 10 fold increase in iron within the mitochondria along with increased ros production [17] and [20] .  
15896810frataxinfrataxin1.0recent evidence suggests that frataxin might detoxify ros via activation of glutathione peroxidase and elevation of thiols [10] .  
15896810frataxinfrataxin1.0transgenic overexpression of human frataxin increases cellular antioxidant defense via activation of glutathione peroxidase and elevation of reduced thiols thereby reducing the incidence of malignant transformation induced by ros as observed b 
15896810frataxinfrataxin1.0there is evidence that frataxin acts as a chaperone for fe ii and a storage compartment for excess iron [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] and [38] .  
15896810frataxinfrataxin1.0this is consistent with the roles played by frataxin in iron export fe_amp_#x2013;s cluster assembly heme biosynthesis and prevention of oxidative stress.  
15896810frataxinfrataxin1.0also frataxin plays a direct role in the mitochondrial energy activation and oxidative phosphorylation [11] .  
15896810frataxinfrataxin1.0in mouse models deletion of the frataxin gene results in embryonic lethality [40] while its selective inactivation in neuronal and cardiac tissues leads to neurological symptoms and cardiomyopathy associated with mitochondrial iron_amp_#x20 
15896810frataxinfrataxin1.0in contrast a model expressing 25_amp_#x2013;35% of wild type frataxin levels by virtue of a gaa 230 expansion inserted in the first intron of the mouse gene has no obvious phenotype [39] .  
15896810frataxinfrataxin1.0the length of the gaa expansion has been shown to determine the amount of frataxin expressed [16] .  
15896810frataxinfrataxin1.0therefore the residual expression of frataxin probably determines the reduced skeletal muscle mitochondrial atp production rate we detected in vivo.  
15896810friedreich ataxiafriedreich ataxia1.0there are evidences of an impairment in vivo of glutathione homeostasis and antioxidant enzymes in patients with friedreich ataxia suggesting a relevant role of free radical cytotoxicity in the pathophysiology of the disease.  
15896810friedreich ataxiafriedreich ataxia1.0in fact a reduction of free glutathione levels in the blood of patients with friedreich ataxia a total glutathione concentration comparable to the controls and a significant increase of glutathione bound to haemoglobin in erythrocytes have been demonstrated in frda patients [128] also associat 
15896810friedreich ataxiafriedreich ataxia1.0a deficiency of the micronutrient has also been reported in patients with friedreich ataxia and there are histological similarities between friedreich's cardiomyopathy and keshan disease.  
15896810friedreich ataxiafriedreich ataxia1.0as iron induced mitochondrial oxidative damage is central to the pathology of friedreich ataxia and in addition some studies suggest a link between frataxin expression glutathione peroxidase gpx activity and oxidative stress the administration of selenium supplements could normalize the antioxi 
15896810frataxinfrataxin1.0as iron induced mitochondrial oxidative damage is central to the pathology of friedreich ataxia and in addition some studies suggest a link between frataxin expression glutathione peroxidase gpx activity and oxidative stress the administration of selenium supplements could normalize the antioxidant activity of myocardial glutathione peroxidase and slow t 
15896810frataxinfrataxin1.0although the precise function of frataxin still remains to be defined frda has clearly been identified as a nuclear encoded mitochondrial disorder.